Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571415 · ClinicalTrials.gov registry record
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
A clinical trial, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- 21
- Enrollment target
NCT00571415: Clinical Trial study, sponsored by Virginia Commonwealth University.
NCT00571415 is a clinical trial that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00571415 was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Within this study patient data are collected from different imaging and motion monitoring devices that will be used to develop and test strategies for image-guided adaptive radiotherapy in cervix cancer patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-03 |
| Est. Completion | 2015-10 |
Why NCT00571415 stopped before completion
NCT00571415 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00571415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00571415 about?
NCT00571415 is a clinical study titled "Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition". Within this study patient data are collected from different imaging and motion monitoring devices that will be used to develop and test strategies for image-guided adaptive radiotherapy in cervix cancer patients.
What is the current status of trial NCT00571415?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2009-03. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT00571415?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia